Feng Liu

发表

Synthesis of Transition-State Inhibitors of Chorismate Utilizing Enzymes from Bromobenzene cis-1,2-Dihydrodiol.

F. Liu, Xiao-Kang Zhang, William D. Fiers, 2017, The Journal of organic chemistry.

DNA Methyltransferase Inhibitors and their Therapeutic Potential.

Huan-qiu Li, Zehao Zhou, Feng Liu, 2019, Current topics in medicinal chemistry.

Abstract A226: Mechanism of action of iniparib: Stimulation of reactive oxygen species (ROS) production in an iniparib-sensitive breast cancer cell line.

D. Bergstrom, J. Watters, J. Pollard, 2011 .

Structure-Based Optimization of Pyridoxal 5'-Phosphate-Dependent Transaminase Enzyme (BioA) Inhibitors that Target Biotin Biosynthesis in Mycobacterium tuberculosis.

B. Finzel, D. Schnappinger, F. Liu, 2017, Journal of medicinal chemistry.

Targeting Mycobacterium tuberculosis Biotin Protein Ligase (MtBPL) with Nucleoside-Based Bisubstrate Adenylation Inhibitors.

B. Finzel, D. Schnappinger, F. Liu, 2015, Journal of medicinal chemistry.

Fragment-based exploration of binding site flexibility in Mycobacterium tuberculosis BioA.

Feng Liu, Dirk Schnappinger, Courtney C Aldrich, 2015, Journal of medicinal chemistry.

Recent progress on the discovery of NLRP3 inhibitors and their therapeutic potential.

F. Liu, Huanqiu Li, Weiwei Wang, 2020, Current medicinal chemistry.

Design, Synthesis, and Biological Evaluations of Hydroxypyridonecarboxylic Acids as Inhibitors of HIV Reverse Transcriptase Associated RNase H.

S. Sarafianos, F. Liu, E. Nagy, 2016, Journal of medicinal chemistry.

Synthesis of trans-caffeate analogues and their bioactivities against HIV-1 integrase and cancer cell lines.

Haibing Li, Wei-xiao Hu, F. Liu, 2008, Bioorganic & medicinal chemistry letters.

Discovery of Mycobacterium tuberculosis InhA Inhibitors by Binding Sites Comparison and Ligands Prediction.

Michael Schroeder, Feng Liu, Thierry Langer, 2016, Journal of medicinal chemistry.

Selective histone deacetylase small molecule inhibitors: recent progress and perspectives

F. Liu, Huan-qiu Li, Haitao Qin, 2017, Expert opinion on therapeutic patents.

Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis.

Joshua A. Bittker, S. Schreiber, B. Finzel, 2015, Chemistry & biology.

Target-based identification of whole-cell active inhibitors of biotin biosynthesis in Mycobacterium tuberculosis.

Joshua A. Bittker, S. Schreiber, B. Finzel, 2015, Chemistry & biology.

Stereocontrolled Synthesis of a Potential Transition-State Inhibitor of the Salicylate Synthase MbtI from Mycobacterium tuberculosis.

Zheng Liu, C. Aldrich, Feng Liu, 2015, The Journal of organic chemistry.

3-Hydroxypyrimidine-2,4-diones as Selective Active Site Inhibitors of HIV Reverse Transcriptase-Associated RNase H: Design, Synthesis, and Biochemical Evaluations.

S. Sarafianos, F. Liu, E. Nagy, 2016, Journal of medicinal chemistry.